# Antimicrobial Locks for Hemodialysis Catheter Infections

> **NCT07074821** · PHASE2 · COMPLETED · sponsor: **Oman Ministry of Health** · enrollment: 100 (actual)

## Conditions studied

- Catheter Related Blood Stream Infection
- Hemodialysis
- Vascular Access

## Interventions

- **DRUG:** Taurolidine citrate 4% and heparin 500

## Key facts

- **NCT ID:** NCT07074821
- **Lead sponsor:** Oman Ministry of Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2024-02-29
- **Final completion:** 2024-07-24
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07074821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07074821, "Antimicrobial Locks for Hemodialysis Catheter Infections". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07074821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*